As of 2026-09-04, the Relative Valuation of Haemonetics Corp (HAE) is 80.37 USD. This relative valuation is based on P/E multiples. With the latest stock price at 102.85 USD, the upside of Haemonetics Corp based on Relative Valuation is -21.9%.
The range of the Relative Valuation is 68.89 - 95.24 USD.
| Range | Selected | |
| Trailing P/E multiples | 32.5x - 43.6x | 36.3x |
| Forward P/E multiples | 28.6x - 34.1x | 30.0x |
| Fair Price | 68.89 - 95.24 | 80.37 |
| Upside | -33.0% - -7.4% | -21.9% |
| Date | P/E |
| 2026-08-31 | 48.65 |
| 2026-08-28 | 49.07 |
| 2026-08-27 | 49.56 |
| 2026-08-26 | 50.32 |
| 2026-08-25 | 51.13 |
| 2026-08-24 | 51.17 |
| 2026-08-21 | 51.36 |
| 2026-08-20 | 51.08 |
| 2026-08-19 | 51.17 |
| 2026-08-18 | 49.40 |
| 2026-08-17 | 42.61 |
| 2026-08-14 | 42.86 |
| 2026-08-13 | 42.66 |
| 2026-08-12 | 43.11 |
| 2026-08-11 | 41.17 |
| 2026-08-10 | 40.88 |
| 2026-08-07 | 41.46 |
| 2026-08-06 | 40.13 |
| 2026-08-05 | 39.46 |
| 2026-08-04 | 40.30 |
| 2026-08-03 | 40.97 |
| 2026-07-31 | 40.38 |
| 2026-07-30 | 40.04 |
| 2026-07-29 | 40.32 |
| 2026-07-28 | 38.96 |
| 2026-07-27 | 37.72 |
| 2026-07-24 | 37.19 |
| 2026-07-23 | 36.53 |
| 2026-07-22 | 36.83 |
| 2026-07-21 | 36.85 |
| 2026-07-20 | 36.90 |
| 2026-07-17 | 36.75 |
| 2026-07-16 | 37.05 |
| 2026-07-15 | 36.19 |
| 2026-07-14 | 35.12 |
| 2026-07-13 | 36.29 |
| 2026-07-10 | 35.96 |
| 2026-07-09 | 35.40 |
| 2026-07-08 | 34.84 |
| 2026-07-07 | 35.35 |
| 2026-07-06 | 35.41 |
| 2026-07-02 | 35.44 |
| 2026-07-01 | 35.33 |
| 2026-06-30 | 35.40 |
| 2026-06-29 | 35.46 |
| 2026-06-26 | 36.48 |
| 2026-06-25 | 36.64 |
| 2026-06-24 | 34.40 |
| 2026-06-23 | 34.35 |
| 2026-06-22 | 34.24 |